Impact Equity Partners has acquired McConnell Labs, and the new owner wasted no time: the company bought Attain Cosmetics and rebranded the combined business as Modern Chemistry Labs in a single corporate restructuring.

The move reshapes a longtime American nail product and skincare manufacturer and positions it, in the company's own framing, for its "next phase" — expanding its reach in professional beauty.

What does the deal change?

Two transactions sit inside the announcement. First, the private equity sale: Impact Equity Partners, an impact-focused fund, took ownership of McConnell Labs. Second, the platform bolt-on: McConnell Labs acquired Attain Cosmetics, a deal that folds Attain's business into the newly named Modern Chemistry Labs entity.

Elizabeth Morris, founder of Attain Cosmetics, joins the combined company as part of the transaction. Her role signals continuity for Attain's existing customers — formulations, order flows and supplier relationships are less likely to be disrupted when a founder stays on through integration.

For procurement teams and distributors carrying either brand, the immediate checklist is administrative rather than technical: updated entity names on invoices, contracts and vendor records; watching for any changes to minimum order quantities, pricing or distribution terms as the new owner integrates operations; and confirming that product documentation — including INCI-declared formulations and safety paperwork — carries over unchanged under the Modern Chemistry Labs name.

Why private equity is the operative detail

The rebrand is not a cosmetic refresh. A sale to Impact Equity Partners puts a financial sponsor behind the manufacturer, and sponsors typically buy platforms with the intent to scale them — through further acquisitions, expanded distribution or capacity investment. The Attain Cosmetics acquisition, announced alongside the rebrand, reads as the first execution of that playbook rather than the last.

For professional buyers, that trajectory usually means a broader catalog under one corporate roof. Nail products and skincare already sat in McConnell Labs' portfolio; Attain adds to the combined offering, and further bolt-ons would compound it.

For competitors, the message is that mid-sized American manufacturers of professional nail and skincare products are consolidating. Brands evaluating contract manufacturing or private label partners should track whether Modern Chemistry Labs leverages its new capital to compete more aggressively on capacity, lead times or pricing.

What to watch next

The transaction has just closed, and the integration details — retention of Attain's product lines, any consolidation of manufacturing sites, leadership structure beyond Morris's involvement — have not been disclosed. Watch for the first post-acquisition announcements from Modern Chemistry Labs: new distribution agreements, additional acquisitions, or capital expenditure statements would each clarify how quickly the new owner intends to scale the platform.

In the nearer term, the next data point is operational: whether Attain Cosmetics customers see any change in service, pricing or product availability as orders shift to the Modern Chemistry Labs entity.